Levi & Korsinsky, LLP announces that a INSD class action lawsuit has been filed on behalf of investors who purchased Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (INSD) securities between December 8, 2020 and November 24, 2021. For more on the INSD Lawsuit please contact us today.
According to the Instadose Pharma Corp. f/k/a Mikrocoze, Inc. lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:
(i) Instadose had performed inadequate due diligence into the business combination with Instadose Canada and/or ignored significant red flags associated with Instadose Canada; (ii) Instadose’s internal controls and policies were inadequate to detect and/or prevent impermissible trading activity by control persons of the Company; (iii) the foregoing subjected Instadose to a heightened risk of regulatory scrutiny and enforcement action; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.
If you suffered a loss in Instadose Pharma Corp. f/k/a Mikrocoze, Inc. you have until February 28, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.